+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Europe Malaria Treatment Market Forecast to 2030 - Regional Analysis - by Treatment, Route of Administration, and Distribution Channel- Product Image
Europe Malaria Treatment Market Forecast to 2030 - Regional Analysis - by Treatment, Route of Administration, and Distribution Channel- Product Image
Sale

Europe Malaria Treatment Market Forecast to 2030 - Regional Analysis - by Treatment, Route of Administration, and Distribution Channel

  • PDF Icon

    Report

  • 87 Pages
  • May 2024
  • Region: Europe
  • The Insight Partners
  • ID: 5732124
UP TO OFF until Dec 31st 2024
Description Jump to:
The Europe malaria treatment market was valued at US$ 451.69 million in 2022 and is expected to reach US$ 3.06 billion by 2030; it is estimated to grow at a CAGR of 27.0% from 2022 to 2030.

Extending Pipeline of New Drugs and Vaccines Drives Europe Malaria Treatment Market

Antimicrobial resistance can put the public at risk of many diseases, such as malaria. To overcome this challenge, the R&D of new medicines is considered the best strategy; as a result, the antimalarial pipeline is becoming increasingly robust. Public-private partnerships are accelerating research activities related to the treatment of malaria. For instance, Medicines for Malaria Venture (MMV), a nonprofit organization, works with numerous pharmaceutical companies to reduce the burden of malaria by developing novel treatment options.

Europe Malaria Treatment Market Overview

According to a surveillance report by ECDC, France reported the highest number of malaria cases in 2020. In 2020, France reported 1,007 confirmed malaria cases. Nearly all the cases reported by EU/EEA countries in 2020 were diagnosed in people traveling to France from other countries; these mostly included individuals linked to travel routes from West Africa. In France, P. falciparum is responsible for almost all severe cases and deaths in travelers. Many research organizations are working toward developing new approaches to eliminate malaria in France. For example, teams at the Institut Pasteur are dedicated to malaria research aiming to develop vaccines. This research is vital in finding new ways of fighting malaria. The Institute Pasteur is also taking part in a major European program named EVIMalaR, which involves 17 research institutes and universities from 7 European countries, and partners from 3 African countries. Such collaborative efforts toward malaria elimination are driving the growth of the malaria treatment market in France.

Europe Malaria Treatment Market Segmentation

The Europe malaria treatment market is segmented based on treatment, route of administration, distribution channel, and country. Based on treatment, the Europe malaria treatment market is segmented into generic drugs, originators, vaccines, and others. The generic drugs segment held the largest market share in 2022.

In terms of route of administration, the Europe malaria treatment market is bifurcated into oral and parenteral. The oral segment held a larger market share in 2022.

By distribution channel, the Europe malaria treatment market is segmented into direct tender, hospital pharmacies, retail pharmacies, online pharmacies, and others. The direct tender segment held the largest market share in 2022.

Based on country, the Europe malaria treatment market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. France dominated the Europe malaria treatment market share in 2022.

Cipla Ltd, Sun Pharmaceutical Industries Ltd, Sanofi SA, GSK Plc, Novartis AG, Pfizer Inc, and Lupin Ltd are some of the leading players operating in the Europe malaria treatment market.

Table of Contents

1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights - Malaria
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Malaria Treatment Market - Key Industry Dynamics
4.1 Key Market Drivers:
4.1.1 Increasing Prevalence of Malaria
4.2 Market Restraints
4.2.1 Availability of Counterfeit Antimalarial Drugs Followed by Subsequent Drug Resistance
4.3 Market Opportunities
4.3.1 Growing Strategic Initiatives by Market Players
4.4 Future Trends
4.4.1 Extending Pipeline of New Drugs and Vaccines
4.5 Impact Analysis
5. Malaria Treatment Market - Europe Market Analysis
5.1 Europe Malaria Treatment Market Revenue (US$ million), 2022 - 2030
6. Europe Malaria Treatment Market - Revenue and Forecast to 2030 - by Treatment
6.1 Overview
6.2 Europe Malaria Treatment Market Revenue Share, by Treatment 2022 & 2030 (%)
6.3 Vaccines
6.3.1 Overview
6.3.2 Vaccines Market Revenue and Forecast to 2030 (US$ Mn)
6.4 Generic Drugs
6.4.1 Overview
6.4.2 Generic Drugs Market Revenue and Forecast to 2030 (US$ Mn)
6.5 Originators
6.5.1 Overview
6.5.2 Originators Market Revenue and Forecast to 2030 (US$ Mn)
6.6 Others
6.6.1 Overview
6.6.2 Others Market Revenue and Forecast to 2030 (US$ Mn)
7. Europe Malaria Treatment Market - Revenue and Forecast to 2030 - by Route of Administration
7.1 Overview
7.2 Europe Malaria Treatment Market Revenue Share, by Route of Administration 2022 & 2030 (%)
7.3 Oral
7.3.1 Overview
7.3.2 Oral: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Parenteral
7.4.1 Overview
7.4.2 Parenteral: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8. Europe Malaria Treatment Market - Revenue and Forecast to 2030 - by Distribution Channel
8.1 Overview
8.2 Europe Malaria Treatment Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
8.3 Direct Tender
8.3.1 Overview
8.3.2 Direct Tender: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Hospital Pharmacies
8.4.1 Overview
8.4.2 Hospital Pharmacies: Malaria Market - Revenue and Forecast to 2030 (US$ Million)
8.4.2.1.1 Malaria Treatment Market, by Hospital Pharmacies
8.5 Retail Pharmacies
8.5.1 Overview
8.5.2 Retail Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.5.2.1.1 Malaria Treatment Market, by Retail Pharmacies
8.6 Online Pharmacies
8.6.1 Overview
8.6.2 Online Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
9. Europe Malaria Treatment Market - Country Analysis
9.1 Europe Malaria Treatment Market, Revenue and Forecast to 2030
9.1.1 Overview
9.1.1.1 Europe: Malaria Treatment Market, by Countries
9.1.1.2 France
9.1.1.3 Overview
9.1.1.3.1 France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
9.1.1.3.2 France: Malaria Treatment Market, by Treatment
9.1.1.3.3 France: Malaria -Malaria Treatment Market, by Route of Administration
9.1.1.3.4 France: Malaria Treatment Market, by Distribution Channel
9.1.1.3.4.1 France: Malaria Treatment Market, by Hospital Pharmacies
9.1.1.3.4.2 France: Malaria Treatment Market, by Retail Pharmacies
9.1.1.4 UK
9.1.1.5 Overview
9.1.1.5.1 UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
9.1.1.5.2 UK: Malaria Treatment Market, by Treatment
9.1.1.5.3 UK: Malaria -Malaria Treatment Market, by Route of Administration
9.1.1.5.4 UK: Malaria Treatment Market, by Distribution Channel
9.1.1.5.4.1 UK: Malaria Treatment Market, by Hospital Pharmacies
9.1.1.5.4.2 UK: Malaria Treatment Market, by Retail Pharmacies
9.1.1.6 Italy
9.1.1.7 Overview
9.1.1.7.1 Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
9.1.1.7.2 Italy: Malaria Treatment Market, by Treatment
9.1.1.7.3 Italy: Malaria -Malaria Treatment Market, by Route of Administration
9.1.1.7.4 Italy: Malaria Treatment Market, by Distribution Channel
9.1.1.7.4.1 Italy: Malaria Treatment Market, by Hospital Pharmacies
9.1.1.7.4.2 Italy: Malaria Treatment Market, by Retail Pharmacies
9.1.1.8 Germany
9.1.1.9 Overview
9.1.1.9.1 Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
9.1.1.9.2 Germany: Malaria Treatment Market, by Treatment
9.1.1.9.3 Germany: Malaria -Malaria Treatment Market, by Route of Administration
9.1.1.9.4 Germany: Malaria Treatment Market, by Distribution Channel
9.1.1.9.4.1 Germany: Malaria Treatment Market, by Hospital Pharmacies
9.1.1.9.4.2 Germany: Malaria Treatment Market, by Retail Pharmacies
9.1.1.10 Spain
9.1.1.11 Overview
9.1.1.11.1 Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
9.1.1.11.2 Spain: Malaria Treatment Market, by Treatment
9.1.1.11.3 Spain: Malaria -Malaria Treatment Market, by Route of Administration
9.1.1.11.4 Spain: Malaria Treatment Market, by Distribution Channel
9.1.1.11.4.1 Spain: Malaria Treatment Market, by Hospital Pharmacies
9.1.1.11.4.2 Spain: Malaria Treatment Market, by Retail Pharmacies
9.1.1.12 Rest of Europe
9.1.1.13 Overview
9.1.1.13.1 Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
9.1.1.13.2 Rest of Europe: Malaria Treatment Market, by Treatment
9.1.1.13.3 Rest of Europe: Malaria -Malaria Treatment Market, by Route of Administration
9.1.1.13.4 Rest of Europe: Malaria Treatment Market, by Distribution Channel
9.1.1.13.4.1 Rest of Europe: Malaria Treatment Market, by Hospital Pharmacies
9.1.1.13.4.2 Rest of Europe: Malaria Treatment Market, by Retail Pharmacies
10. Malaria Treatment Market Industry Landscape
10.1 Overview
10.2 Growth Strategies in the Malaria Treatment Market
10.3 Inorganic Growth Strategies
10.3.1 Overview
10.4 Organic Growth Strategies
10.4.1 Overview
11. Company Profiles
11.1 Cipla Ltd
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Sun Pharmaceutical Industries Ltd
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Sanofi SA
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 GSK Plc
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Novartis AG
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Pfizer Inc
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Service
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Lupin Ltd
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
12. Appendix
12.1 About Us
12.2 Glossary of Terms
List of Tables
Table 1. Malaria Treatment Market Segmentation
Table 2. Malaria Drugs/Vaccine/Compounds Under Clinical Development
Table 3. Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 4. Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
Table 5. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 6. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 7. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 8. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 9. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
Table 10. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 11. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 12. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 13. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 14. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
Table 15. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 16. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 17. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 18. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 19. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
Table 20. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 21. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 22. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 23. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 24. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
Table 25. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 26. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 27. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 28. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 29. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
Table 30. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 31. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 32. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 33. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 34. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
Table 35. Recent Inorganic Growth Strategies in the Malaria Treatment Market
Table 36. Recent Organic Growth Strategies in the Malaria Treatment Market
Table 37. Glossary of Terms, Malaria Treatment Market
List of Figures
Figure 1. Malaria Treatment Market - Key Industry Dynamics
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. Europe Malaria Treatment Market Revenue (US$ million), 2022 - 2030
Figure 4. Europe Malaria Treatment Market Revenue Share, by Treatment 2022 & 2030 (%)
Figure 5. Vaccines Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 6. Generic Drugs Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 7. Originators Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 8. Others Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 9. Europe Malaria Treatment Market Revenue Share, by Route of Administration 2022 & 2030 (%)
Figure 10. Oral: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Parenteral: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Europe Malaria Treatment Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
Figure 13. Direct Tender: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Hospital Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Retail Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Online Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Others: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Europe Malaria Treatment Market, By Country, 2022 ($Mn)
Figure 19. Europe: Malaria Treatment Market, By Key Countries, 2022 and 2030 (%)
Figure 20. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 21. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 22. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 23. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 24. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 25. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 26. Growth Strategies in the Malaria Treatment Market

Companies Mentioned

  • Cipla Ltd
  • Sun Pharmaceutical Industries Ltd
  • Sanofi SA
  • GSK Plc
  • Novartis AG
  • Pfizer Inc
  • Lupin Ltd

Related Topics

Related Reports

Malaria Treatment Global Market Report 2024 - Product Image

Malaria Treatment Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Infectious Disease Therapeutics Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Drug Class, Indication, Route of Administration, Distribution Channel - Product Image

Infectious Disease Therapeutics Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Drug Class, Indication, Route of Administration, Distribution Channel

  • Report
  • 193 Pages
  • Global
From
Middle East & Africa Malaria Treatment Market Forecast to 2030 - Regional Analysis - by Treatment, Route of Administration, and Distribution Channel - Product Image

Middle East & Africa Malaria Treatment Market Forecast to 2030 - Regional Analysis - by Treatment, Route of Administration, and Distribution Channel

  • Report
  • 120 Pages
  • Africa, Middle East
From
Antimalarial Drugs Market by Drug Class, Drug Type, Route of Administration, Malaria Type, Distribution Channel, End User - Global Forecast 2025-2030 - Product Image

Antimalarial Drugs Market by Drug Class, Drug Type, Route of Administration, Malaria Type, Distribution Channel, End User - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From
Artemisinin Market by Type By Application, by Distribution Channel, and By Region - Product Image

Artemisinin Market by Type By Application, by Distribution Channel, and By Region

  • Report
  • 200 Pages
  • Global
From

About the Malaria Drug Market

The Malaria Drug market is a subset of the larger Infectious Diseases Drugs market. Malaria is a mosquito-borne disease caused by a parasite, and is one of the leading causes of death in the world. Malaria drugs are used to treat and prevent the disease, and are typically administered orally or intravenously. The market for malaria drugs is highly competitive, with a range of generic and branded products available. The market is driven by the increasing prevalence of malaria, as well as the need for new and improved treatments. The market is also influenced by government policies and regulations, as well as the availability of funding for research and development. Additionally, the market is affected by the availability of new technologies, such as rapid diagnostic tests and vaccines. Some companies in the Malaria Drug market include Novartis, GlaxoSmithKline, Sanofi, Merck, and Pfizer. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.